Multiple Sclerosis Discovery Forum

Inspiring Connections

Most Viewed

Hypovitaminosis D upscales B-cell immunoreactivity in multiple sclerosis.
The value of qualitative and quantitative assessment of lesion to cerebral cortex signal ratio on double inversion recovery sequence in the differentiation of demyelinating plaques from non-specific T2 hyperintensities.
Clarity Extension Study
12-oxo-phytodienoic acid, a plant-derived oxylipin, attenuates lipopolysaccharide-induced inflammation in microglia.
Genzyme receives positive CHMP opinion for LEMTRADA™ (alemtuzumab) in Europe
A validated gene regulatory network and GWAS identifies early regulators of T cell-associated diseases.
Assessment of structural and functıonal vısual outcomes ın relapsıng remıttıng multıple sclerosıs wıth vısual evoked potentıals and optıcal coherence tomography.
A dual concurrent mechanism explains trigeminal neuralgia in patients with multiple sclerosis.
Hydrogen-rich water improves neurological functional recovery in experimental autoimmune encephalomyelitis mice.
B cell depletion therapy ameliorates autoimmune disease through ablation of IL-6-producing B cells.
Myelin Basic Protein Citrullination in Multiple Sclerosis: A Potential Therapeutic Target for the Pathology.
Kaposi sarcoma in a fingolimod-treated patient with multiple sclerosis.
New data reinforce efficacy of TECFIDERA® (dimethyl fumarate) in MS patients with high disease activity
[Neurophysiology in Guillain-Barré syndrome].
Secondary Progressive Multiple Sclerosis: Definition and Measurement.
Neuroimmunology: Clostridium-reactive T cells are implicated in the pathogenesis of neuromyelitis optica.
Mutually enhancing anti-inflammatory activities of dimethyl fumarate and NF-κB inhibitors - Implications for dose-sparing combination therapies.
Neuro-Immune Interactions at Barrier Surfaces.
Geography in multiple sclerosis.
Immuno-modulatory Properties of a Quinolin-2-(1H)-on-3-carboxamide Derivative: Relevance in Multiple Sclerosis.
Disease-modifying drugs for multiple sclerosis in pregnancy: A systematic review.
Will the real multiple sclerosis please stand up?
Effect of BG-12 on contrast-enhanced lesions in patients with relapsing--remitting multiple sclerosis: subgroup analyses from the phase 2b study.
Compliance to fingolimod and other disease modifying treatments in multiple sclerosis patients, a retrospective cohort study.
In Vivo Maintenance of Human Regulatory T Cells during CD25 Blockade.

Pages